Overview
Snap-8, also known as Acetyl Octapeptide-3, is a synthetic peptide developed as an analogue of Argireline®. It is commonly utilised in laboratory research involving peptide structure, SNARE complex–associated pathways, and cellular signalling systems.
Snap-8 is an octapeptide composed of eight amino acids. In controlled research environments, it is used as a model compound in studies involving peptide interactions, SNARE complex systems, and experimental biological frameworks.
Chemical reference information: Molecular formula: C₄₁H₆₈N₁₂O₁₃; Molecular weight: 993.1 g/mol; Sequence: Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂. These reference identifiers describe the formulation; the batch-specific analytical record identifies the supplied material.
Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.
Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.
NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.
Snap-8 10 mg is offered as a NORVEXA research vial. The selected strength refers to the compound content of this vial reference. Request the matching batch record for identity, analytical specifications, and presentation details.
Handling and storage
Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.
Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.
NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.